Literature DB >> 15458560

Long-term outcome of offspring after maternal severe puerperal disorder.

R Abbott1, V J Dunn, S A Robling, E S Paykel.   

Abstract

OBJECTIVE: To study adult mental health in offspring of mothers who experienced severe puerperal disorder.
METHOD: Mothers, followed up a mean of 23 years after puerperal disorder requiring hospitalization, were interviewed regarding adult psychiatric illness, childhood neurotic symptoms and conduct problems of 48 offspring of the index episode and 62 additional siblings.
RESULTS: In these predominantly young adults the lifetime rate of ICD-10 adult psychiatric illness was 26%, and was higher in offspring of puerperal episodes (35% vs. 15%, P = 0.07). There were also high rates of childhood symptoms and problems.
CONCLUSION: There are high lifetime rates of adult psychiatric illness in young adult offspring of mothers with puerperal disorder, which are likely to increase further with time, and warrant special attention.

Entities:  

Mesh:

Year:  2004        PMID: 15458560     DOI: 10.1111/j.1600-0447.2004.00406.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  3 in total

1.  Poor Postpartum Sleep Quality Predicts Subsequent Postpartum Depressive Symptoms in a High-Risk Sample.

Authors:  Katherine M McEvoy; Divya Rayapati; Katie O Washington Cole; Courtney Erdly; Jennifer L Payne; Lauren M Osborne
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

Review 2.  Neuroactive Steroids and Perinatal Depression: a Review of Recent Literature.

Authors:  Katherine McEvoy; Jennifer L Payne; Lauren M Osborne
Journal:  Curr Psychiatry Rep       Date:  2018-08-09       Impact factor: 5.285

3.  Evaluation of Lay Support in Pregnant women with Social risk (ELSIPS): a randomised controlled trial.

Authors:  Sara Kenyon; Kate Jolly; Karla Hemming; Lucy Ingram; Nicola Gale; Sophie-Anna Dann; Jacky Chambers; Christine MacArthur
Journal:  BMC Pregnancy Childbirth       Date:  2012-02-29       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.